IC19 CAR-T Cell Therapy

· Beijing Immunochina Medical Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IC19 CAR-T Cell Therapy, covering 2025-03-24 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]

See pricing